Quest Diagnostics Inc
Closed
SectorHealthcare
193.88 -2.04
Overview
Share price change
24h
Min
193.27
Max
194.96
Income | 19M 264M |
|---|---|
Sales | 89M 2.9B |
P/E Sector Avg | 22.316 49.712 |
EPS | 2.5 |
Dividend yield | 1.61 |
Profit margin | 9.119 |
Employees | 57,000 |
EBITDA | 33M 434M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +14.43% upside |
Dividend yield Sector Avg | 1.61% 2.36% |
|---|---|
Next Earnings | 23 lip 2026 |
Next Dividend date | 22 lip 2026 |
Next Ex Dividend date | 8 lip 2026 |
Market Cap | 652M 22B |
|---|---|
Previous open | 195.92 |
Previous close | 193.88 |
News Sentiment
By Acuity
50%
50%
123 / 342 Ranking in Healthcare
Quest Diagnostics Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
About Quest Diagnostics Inc
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.